Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |